drugset / Trial / NCT03706053
Midodrine Use in Septic Shock
RandomizedParallel-groupTriple-blindTreatment
Summary
The investigators aim to perform a randomized, double-blind, placebo-controlled trial to investigate the efficacy of midodrine in decreasing time to IV vasopressor liberation in patients with septic shock.
Timeline
- Start
- 2018-11-05
- Primary completion
- 2022-02-11
- Completion
- 2022-02-11
Outcome
Outcome not reported
Stopped (Business): “No funding for the study; not enough staff”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Midodrine | Small molecule | 10 mg | Other |
| Subject | Midodrine | Small molecule | 20 mg | Other |